Sartorius Aktiengesellschaft - Asset Resilience Ratio
Sartorius Aktiengesellschaft (SRT3) has an Asset Resilience Ratio of 0.26% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check SRT3 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2025)
This chart shows how Sartorius Aktiengesellschaft's Asset Resilience Ratio has changed over time. See Sartorius Aktiengesellschaft balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Sartorius Aktiengesellschaft's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sartorius Aktiengesellschaft (SRT3) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €26.10 Million | 0.26% |
| Total Liquid Assets | €26.10 Million | 0.26% |
Asset Resilience Insights
- Limited Liquidity: Sartorius Aktiengesellschaft maintains only 0.26% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sartorius Aktiengesellschaft Industry Peers by Asset Resilience Ratio
Compare Sartorius Aktiengesellschaft's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
|
Daxor Corporation
NASDAQ:DXR |
Medical Instruments & Supplies | 65.10% |
|
GETS Global Bhd
KLSE:5079 |
Medical Instruments & Supplies | 0.03% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Safe Orthopaedics SA
PA:ALSAF |
Medical Instruments & Supplies | 2.20% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
Annual Asset Resilience Ratio for Sartorius Aktiengesellschaft (2008–2025)
The table below shows the annual Asset Resilience Ratio data for Sartorius Aktiengesellschaft.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.68% | €551.70 Million ≈ $645.00 Million |
€9.72 Billion ≈ $11.36 Billion |
-2.52pp |
| 2024-12-31 | 8.20% | €828.70 Million ≈ $968.84 Million |
€10.10 Billion ≈ $11.81 Billion |
+4.16pp |
| 2023-12-31 | 4.04% | €394.20 Million ≈ $460.86 Million |
€9.76 Billion ≈ $11.40 Billion |
+1.22pp |
| 2022-12-31 | 2.82% | €196.80 Million ≈ $230.08 Million |
€6.98 Billion ≈ $8.16 Billion |
-3.51pp |
| 2021-12-31 | 6.34% | €360.99 Million ≈ $422.03 Million |
€5.70 Billion ≈ $6.66 Billion |
+1.70pp |
| 2020-12-31 | 4.63% | €217.65 Million ≈ $254.45 Million |
€4.70 Billion ≈ $5.49 Billion |
+2.30pp |
| 2019-12-31 | 2.33% | €66.40 Million ≈ $77.63 Million |
€2.84 Billion ≈ $3.33 Billion |
-0.33pp |
| 2018-12-31 | 2.67% | €67.34 Million ≈ $78.73 Million |
€2.53 Billion ≈ $2.95 Billion |
-0.59pp |
| 2017-12-31 | 3.25% | €74.68 Million ≈ $87.31 Million |
€2.30 Billion ≈ $2.69 Billion |
-0.86pp |
| 2016-12-31 | 4.11% | €72.07 Million ≈ $84.25 Million |
€1.75 Billion ≈ $2.05 Billion |
+3.54pp |
| 2015-12-31 | 0.58% | €8.28 Million ≈ $9.68 Million |
€1.44 Billion ≈ $1.68 Billion |
-0.34pp |
| 2014-12-31 | 0.91% | €11.63 Million ≈ $13.60 Million |
€1.27 Billion ≈ $1.49 Billion |
-0.07pp |
| 2013-12-31 | 0.98% | €11.54 Million ≈ $13.49 Million |
€1.17 Billion ≈ $1.37 Billion |
+1.09pp |
| 2012-12-31 | -0.11% | €-1.17 Million ≈ $-1.36 Million |
€1.07 Billion ≈ $1.25 Billion |
-0.02pp |
| 2011-12-31 | -0.08% | €-819.00K ≈ $-957.50K |
€963.84 Million ≈ $1.13 Billion |
+0.31pp |
| 2008-12-31 | -0.40% | €-3.45 Million ≈ $-4.04 Million |
€865.00 Million ≈ $1.01 Billion |
-- |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more